Q3 FY2025 · ended Sep 30, 2025 · Revenue $16.21M, +7.9% YoY · Filed Oct 31, 2025
DNA X, Inc. (SONM) files with the SEC under industry code 3661, Telephone & Telegraph Apparatus.
Revenue
$16.21M
+7.9% vs year-ago quarter
Net income
$-1.25M
+83.3% vs year-ago quarter
Operating cash flow
$-2.00M
+59.0% vs year-ago quarter
Free cash flow
$-4.52M
-715.3% vs prior quarter
EPS
$-0.92
+93.5% vs year-ago quarter
Dividend per share
None
Shares outstanding
1.49M
-91.6% vs year-ago quarter
Net cash
$123,000
Q1 FY2026
Operating margin
-2.7%
TTM
Company profile
- Industry
- Telephone & Telegraph Apparatus (SIC 3661)
- Listed as
- SONM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1178697
- Former names
- SONIM TECHNOLOGIES INC (until Jan 23, 2026)
Other Telephone & Telegraph Apparatus companies
- Ciena Corp CIEN
- Fabrinet FN
- Clearfield, Inc. CLFD
- ADTRAN Holdings, Inc. ADTN
- Audiocodes Ltd AUDC
- Franklin Wireless Corp FKWL
- Voip-pal.com Inc VPLM
- Clearone Inc CLRO
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | — | — | — | $16.2M | $11.2M |
| Operating income | -$1.3M | -$3.6M | $4.7M | -$4.0M | -$1.5M |
| Net income | -$1.2M | $6.3M | -$8.9M | -$4.8M | -$7.5M |
| Diluted EPS | -$0.92 | $5.01 | -$8.54 | -$4.83 | -$14.15 |
| Operating cash flow | -$2.0M | -$3.5M | -$2.0M | -$7.0M | -$4.9M |
| Total assets | $4.5M | $4.8M | $43.9M | $40.2M | $36.1M |
| Total liabilities | $5.7M | $4.9M | $50.6M | $40.9M | $37.4M |
| Stockholders' equity | -$1.2M | -$983,000 | -$8.0M | -$701,000 | -$1.3M |
| Cash and investments | $900,000 | $1.2M | $1.3M | $2.1M | $2.0M |
| Total debt | — | $1.1M | $5.1M | $5.1M | $2.9M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Aug 31, 2026 | Aug 28, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 27, 2026 | Aug 21, 2026 |
| 10-Q | Quarterly report | Aug 19, 2026 | Jun 30, 2026 |
| 8-K/A |
Amended current report
Unregistered share sale, Other events
|
Aug 13, 2026 | Jun 29, 2026 |
| 8-K/A |
Amended current report
Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Jul 9, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
|
Jul 2, 2026 | Jun 29, 2026 |
All 542 DNA X, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.